Nektar Therapeutics (NKTR) ROE US GAAP (year values)

2020 2021 2022 2022 2023   LTM ?
ROE, % ? -41.3% -77.1% -100.4% -100.4% -210.8%   -344.3%
Changes by years, y/y, % -10pp -36pp -23pp 0pp -110pp    

Nektar Therapeutics. ROE, %

Nektar Therapeutics. ROE, changes, pp

Nektar Therapeutics (NKTR) ROE US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
ROE, % ? -184.3% -210.8% -138.8% -222.2% -344.3%   -344.3%
Changes by years, y/y, % -74pp -110pp +33pp -66pp -160pp    
Changes by quarters, q/q, % -28pp -26pp +72pp -83pp -122pp    

Nektar Therapeutics. ROE, %

Nektar Therapeutics. ROE, changes, pp

Nektar Therapeutics. ROE, changes, pp